Equity and representativeness in pragmatic drug trials: methodological and ethical considerations

BMJ Evid Based Med. 2026 Apr 24:bmjebm-2025-114106. doi: 10.1136/bmjebm-2025-114106. Online ahead of print.
No abstract available

Keywords: Cardiovascular Diseases; Drug Development; Ethics.